|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.58 EUR | -1.64% |
|
-5.25% | +3.49% |
| 03-05 | Moody's Affirms Eurofins Scientific's Ratings, Outlook on Solid Operating Performance in FY25 | MT |
| 02-17 | CIC Corporate Upgrades Eurofins Scientific to Buy Rating, Boosts PT | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Analytical Testing | 6.72B | 6.71B | 6.51B | 6.95B | 7.3B | |||||
Total Assets | 9.33B | 10.08B | 10.89B | 10.89B | 10.99B | |||||
Interest Expense | -94.3M | -91.6M | -123M | -146M | -154M | |||||
Income Tax Expense | 274M | 174M | 116M | 149M | 181M | |||||
CAPEX | -520M | -660M | -478M | -454M | -760M | |||||
EBT | 1.06B | 780M | 423M | 555M | 654M | |||||
D&A | 526M | 580M | 621M | 633M | 655M | |||||
Net Income | 783M | 610M | 310M | 406M | 475M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Europe | 4.05B | 3.56B | 3.36B | 3.6B | 3.88B | |||||
Total Assets | 4.19B | 4.34B | 4.44B | 4.5B | 4.89B | |||||
Interest Expense | - | -13.7M | -21.4M | -23.5M | -22.8M | |||||
Income Tax Expense | 153M | 65.9M | 30.8M | 41.2M | 31.8M | |||||
D&A | 226M | 222M | 260M | 266M | 282M | |||||
CAPEX | -210M | -227M | -194M | -188M | -195M | |||||
Net Income | 732M | 452M | 104M | 230M | 287M | |||||
EBT | 885M | 518M | 135M | 271M | 319M | |||||
Operating Income | 897M | 531M | 155M | 293M | 340M | |||||
EBITDA | 1.17B | 680M | 463M | 598M | 668M | |||||
North America | 2.18B | 2.53B | 2.54B | 2.7B | 2.72B | |||||
Total Assets | 3.65B | 4B | 3.87B | 4.45B | 4.07B | |||||
Interest Expense | - | -21.7M | -15.9M | -17.5M | -16.1M | |||||
Income Tax Expense | 42.4M | 50M | 26.3M | 32.3M | 66.6M | |||||
D&A | 141M | 167M | 173M | 189M | 204M | |||||
CAPEX | -144M | -260M | -215M | -201M | -208M | |||||
Net Income | 336M | 372M | 369M | 408M | 385M | |||||
EBT | 378M | 422M | 395M | 440M | 452M | |||||
Operating Income | 397M | 444M | 411M | 457M | 468M | |||||
EBITDA | 608M | 642M | 654M | 721M | 748M | |||||
Rest of The World | 603M | 733M | 725M | 770M | 810M | |||||
Total Assets | 1.02B | 1.25B | 1.24B | 1.26B | 1.18B | |||||
Interest Expense | - | -9M | -11M | -10.1M | -12.9M | |||||
Income Tax Expense | 19.9M | 10.9M | 15.6M | 13.1M | 15.2M | |||||
D&A | 46M | 63.7M | 74.2M | 78M | 77.7M | |||||
CAPEX | -54.6M | -87.6M | -68.2M | -68.4M | -48.3M | |||||
Net Income | 87.5M | 53.2M | 27M | 43M | 71M | |||||
EBT | 107M | 64M | 42.6M | 56.1M | 86.2M | |||||
Operating Income | 109M | 71.5M | 52.6M | 65.1M | 97.7M | |||||
EBITDA | 165M | 143M | 139M | 161M | 189M | |||||
Group Service Functions | - | - | 100K | - | - | |||||
Total Assets | 472M | 491M | 1.33B | 668M | 840M | |||||
Interest Expense | - | -94.8M | -81.5M | -100M | -114M | |||||
Income Tax Expense | 58.3M | 47.4M | 42.8M | 62.5M | 67.5M | |||||
D&A | 36.8M | 51.6M | 58.1M | 64.1M | 66M | |||||
CAPEX | -85.9M | -70.9M | -66.6M | -61.3M | -70.8M | |||||
Net Income | -372M | -272M | -192M | -275M | -270M | |||||
EBT | -314M | -224M | -149M | -212M | -202M | |||||
Operating Income | -145M | -130M | -88.2M | -135M | -120M | |||||
EBITDA | -106M | -50.8M | -21.8M | -40.9M | -43.9M | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBITDA | - | - | - | - | - | |||||
UK and Ireland | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Nordic Region | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
France | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Germany | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Benelux | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Inter-Segment Revenues | -114M | -112M | -111M | -119M | -117M |
- Stock Market
- Equities
- ERF Stock
- Financials Eurofins Scientific SE
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition